Skip to main content
Log in

One-year evaluation of clinical and immunological efficacy and safety of sublingual versus subcutaneous allergen immunotherapy in allergic conjunctivitis

  • Medical Ophthalmology
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

Background

The aim of this study is to evaluate the clinical and immunological efficacy and safety of allergen immunotherapy (AIT) in patients with allergic conjunctivitis (AC) and to compare between sublingual and subcutaneous routes of administration.

Methods

A prospective comparative case series study was performed on 100 patients with IgE-mediated AC. Patients were referred to allergy clinics for skin prick test (SPT) and AIT. Patients with positive SPT and high-serum IgE level were enrolled in this study. Patients were divided into two groups: sublingual immunotherapy (SLIT) group (50 patients) and subcutaneous immunotherapy (SCIT) group (50 patients). Both groups were followed for 1 year. Efficacy was assessed clinically by comparing pre- and post-treatment symptoms and medication scores and assessed immunologically by comparing pre- and post-treatment serum IgE level and wheal diameter of SPT. Safety of the therapy was assessed by the occurrence of adverse reactions and patient tolerability to the therapy.

Results

Patients were either mono- or polysensitized to different allergens. Aeroallergens were significantly more common than food allergens (P = 0.00). The most prevalent aeroallergens were pollens (40%) and house dust (30%). At 12-month follow-up, both routes SLIT and SCIT led to a statistically significant clinical and immunological improvement (P < 0.05). This improvement was evident in all follow-up parameters including total ocular symptom score (TOSS), medication score, total serum IgE level, and wheal diameter of skin prick test (SPT). There was no significant difference between the two routes of administration (SLIT & SCIT) in any of the follow-up parameters (P > 0.05). Patients were able to tolerate the allergen therapy without developing any serious adverse events.

Conclusion

Aeroallergen polysensitization is common among patients with AC. SPT should be included in the diagnostic workup of those patients. AIT is a safe and effective treatment option for patients with AC as it has the potential to achieve significant reduction in symptom and medication scores without ocular or systemic side effects. There is no significant difference between both routes of administration either SLIT or SCIT in achieving clinical and immunologic improvement; so the patient can choose his preferred method for therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Chigbu DI (2009) The pathophysiology of ocular allergy: a review. Cont Lens Anterior Eye:3–15

  2. La Rosa M, Lionetti E, Reibaldi M et al (2013) Allergic conjunctivitis: a comprehensive review of the literature. Ital J Pediatr 14(39):18

    Article  Google Scholar 

  3. del Cuvillo A, Sastre J, Montoro J (2009) Allergic conjunctivitis and H1 antihistamines. J Investig Allergol Clin Immunol 19:11–18

    PubMed  Google Scholar 

  4. Cox L, Williams B, Sicherer S et al (2008) Pearls and pitfalls of allergy diagnostic testing: report from the American college of allergy, asthma and immunology/American academy of allergy, asthma and immunology specific IgE test task force. Ann Allergy Asthma Immunol 101:580–592

    Article  PubMed  Google Scholar 

  5. Heinzerling L, Mari A, Bergmann K-C et al (2013) The skin prick test – European standards. Clin Transl Allergy 3:3

    Article  PubMed  PubMed Central  Google Scholar 

  6. Bacharier LB, Boner A, Carlsen KH et al (2008) Diagnosis and treatment of asthma in childhood: a PRACTALL consensus report. Allergy 63:5e34

    Google Scholar 

  7. Petalas K, Durham SR (2013) Allergen immunotherapy for allergic rhinitis. Rhinology 51:99–110

    Article  CAS  PubMed  Google Scholar 

  8. Mahdy R, Nada W, Shahien E et al (2010) Hypo sensitization in the treatment of resistant cases of vernal keratoconjunctivitis. Cutan Ocul Toxicol 29:198–202

    Article  PubMed  Google Scholar 

  9. Huggins JL, Looney RJ (2004) Allergen immunotherapy. Am Fam Physician 70:689–696

    PubMed  Google Scholar 

  10. Dreborg S (2001) Histamine reactivity of the skin. Allergy 56:359–364

    Article  CAS  PubMed  Google Scholar 

  11. Kapp A, Demarteau N (2006) Cost effectiveness of levocetirizine in chronic idiopathic urticaria: a pooled analysis of two randomized controlled trials. Clin Drug Investig 26:1–11

    Article  PubMed  Google Scholar 

  12. Marogna M, Spadolini I, Massolo A et al (2005) Clinical, functional, and immunologic effects of sublingual immunotherapy in birch pollinosis: a 3-year randomized controlled study. J Allergy Clin Immunol 115:1184–1185

    Article  PubMed  Google Scholar 

  13. Cox L, Li JT, Nelson H et al (2007) Allergen immunotherapy: a practice parameter - second update. J Allergy Clin Immunol 120:S25–S85

    Article  Google Scholar 

  14. SayedElah MA, Nasr N, Akr H (2015) Subcutaneous versus sublingual immunotherapy for allergic rhinitis therapy: which is superior. Int J Immunol:42–46

  15. Williams TC et al (2013) Recognition of allergic conjunctivitis in patients with allergic rhinitis. World Allergy Organ J 6:4

    Article  PubMed  PubMed Central  Google Scholar 

  16. Canonica GW, Baena-Cagnani CE, Bousquet J (2007) Recommendations for standardization of clinical trials with allergen specific immunotherapy for respiratory allergy. Allergy 62:317–324

    Article  CAS  PubMed  Google Scholar 

  17. Almaliotis D1, Michailopoulos P, Gioulekas D et al (2013) Allergic conjunctivitis and the most common allergens in northern Greece. World Allergy Organ J 6:12

    Article  PubMed  PubMed Central  Google Scholar 

  18. Navarro A, MD Colás C, Antón E et al (2009) Epidemiology of allergic rhinitis in allergy consultations in Spain:Alergologica 2005. J Investig Allergol Clin Immunol 19:7–13

    PubMed  Google Scholar 

  19. Al-Rabia MW (2015) Food-induced immunoglobulin E-mediated allergic rhinitis. J Microsc Ultrastruct 4:69–75

    Article  PubMed  PubMed Central  Google Scholar 

  20. Bielory L (2010) Allergic conjunctivitis and the impact of allergic rhinitis. Curr Allergy Asthma Rep 10:122–134

    Article  PubMed  Google Scholar 

  21. Ciprandi G, Cirillo I (2011) Monosensitization and polysensitization in allergic rhinitis. Eur J Intern Med 22:75–79

    Article  Google Scholar 

  22. Popescu FD (2015) Cross-reactivity between aeroallergens and food allergens. World J Methodol 5:31–50

    Article  PubMed  PubMed Central  Google Scholar 

  23. Ciprandi G, Alesina R, Ariano R, Aurnia P et al (2008) Characteristics of patients with allergic polysensitization: the polismail study. Eur Ann Allergy Clin Immunol 40:77–83

    CAS  PubMed  Google Scholar 

  24. Fasce L, Tosca MA, Baroffio M et al (2007) Atopic infants with wheezing start always with monosensitization. All Asthma Proc 28:449–453

    Article  Google Scholar 

  25. Ibrahim B, Abdel-Latif R (2018) Comparison between sublingual immunotherapy and subcutaneous immunotherapy in the treatment of pollen-induced vernal keratoconjunctivitis in children. Delta J Ophthalmol 19:1–8

    Article  Google Scholar 

  26. Radtke M, Grammer L (2008) Subcutaneous administration of allergen vaccines. Clin Allergy Immunol 21:321–332

    CAS  PubMed  Google Scholar 

  27. Kovesi T, Schuh S, Spier S et al (2010) Achieving control of asthma in preschoolers. CMAJ 182:172–183

    Article  Google Scholar 

  28. Yukselen A, Kendirli S, Yilmaz M et al (2012) Effect of one-year subcutaneous and sublingual immunotherapy on clinical and laboratory parameters in children with rhinitis and asthma: a randomized, placebo controlled, double-blind, double-dummy study. Int Arch Allergy Immunol 157:288–298

    Article  CAS  PubMed  Google Scholar 

  29. Ishida W, Fukuda K, Harada Y et al (2014) Oral immunotherapy for allergic conjunctivitis. Cornea 33:32–36

    Article  Google Scholar 

  30. Prakash OM, Murthy KR (1992) Immunotherapy in allergic conjunctivitis. Indian J Ophthalmol 40:9–10

    CAS  PubMed  Google Scholar 

  31. Musa F, Al-Ahmad M, Arifhodzic N, Al-Herz W (2017) Compliance with allergen immunotherapy and factors affecting compliance among patients with respiratory allergies. Hum Vaccin Immunother 13:514–517

    Article  PubMed  Google Scholar 

  32. Saporta D (2012) Efficacy of sublingual immunotherapy versus subcutaneous injection immunotherapy in allergic patients. J Environ Public Health:492–405

  33. Mauro M, Russello M, Incorvaia C et al (2011) Birch-apple syndrome treated with birch pollen immunotherapy. Int Arch Allergy Immunol 156:416–422

    Article  PubMed  Google Scholar 

  34. Antúnez C, Mayorga C, Corzo JL et al (2008) Two-year follow-up of immunological response in mite-allergic children treated with sublingual immunotherapy. Comparison with subcutaneous administration. Pediatr Allergy Immunol 19:210–218

    Article  PubMed  Google Scholar 

  35. Nelson HS (2014) Subcutaneous immunotherapy versus sublingual immunotherapy: which is more effective? J Allergy Clin Immunol Pract 2:144–149

    Article  PubMed  Google Scholar 

  36. Kim KW, Kim EA, Kwon BC et al (2006) Comparison of allergic indices in monosensitized and polysensitized patients with childhood asthma. J Korean Med Sci 21:1012–1016

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Khulood M. Sayed.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in the study were in accordance with the ethical standards of institutional and national research committee and with 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This study does not present any studies with animals performed by any of the authors.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sayed, K.M., Kamel, A.G. & Ali, A.H. One-year evaluation of clinical and immunological efficacy and safety of sublingual versus subcutaneous allergen immunotherapy in allergic conjunctivitis. Graefes Arch Clin Exp Ophthalmol 257, 1989–1996 (2019). https://doi.org/10.1007/s00417-019-04389-w

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-019-04389-w

Keywords

Navigation